Pregled bibliografske jedinice broj: 600012
Intensity and distribution of immunohistochemical expression of galectin-3 in thyroid neoplasms
Intensity and distribution of immunohistochemical expression of galectin-3 in thyroid neoplasms // Acta Clinica Croatica, 51 (2012), 2; 237-241 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 600012 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Intensity and distribution of immunohistochemical expression of galectin-3 in thyroid neoplasms
Autori
Mateša-Anić, Dubravka ; Moslavac, Sandra ; Mateša, Neven ; Čupić, Hrvoje ; Kusić Zvonko
Izvornik
Acta Clinica Croatica (0353-9466) 51
(2012), 2;
237-241
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Galectin-3; Immunohistochemistry; Thyroid tumors
Sažetak
The aim of the study was to assess the intensity and distribution of galectin-3 expression in benign and malignant thyroid neoplasms by immunohistochemical method. Immunohistochemical expression of galectin-3 was analyzed in surgical thyroid specimens from 82 patients with histopathologic diagnosis of follicular adenoma (n=32), Hürthle cell adenoma (n=10) and papillary carcinoma (n=40). Results of intracytoplasmatic and intranuclear expression of galectin-3 were scored using a semi-quantitative scale for intensity. Intracytoplasmatic expression of galectin-3 was positive in 18 (43%) benign neoplasms and in all 40 malignant neoplasms. The accuracy, sensitivity and specificity of intracytoplasmatic expression of galectin-3 as a malignant marker in thyroid neoplasms were 78.1%, 100% and 57.1%, respectively. Intracytoplasmatic expression of galectin-3 was positive in 10 (31%) cases of follicular adenoma and 8 (80%) cases of Hürthle cell adenoma. The accuracy, sensitivity and specificity of intranuclear expression of galectin-3 as a malignant marker in thyroid neoplasms were 84.1%, 100% and 69%, respectively. There was no strong intensity of either intracytoplasmatic or intranuclear expression of galectin-3 in benign thyroid neoplasms, and no weak intensity of either intracytoplasmatic or intranuclear expression of galectin-3 in malignant neoplasms. There was no statistically significant difference between intracytoplasmatic and intranuclear expression of galectin-3 in benign thyroid neoplasms. The results of our study indicate that the immunohistochemical expression of galectin-3 is a highly sensitive marker of malignancy, with low specificity in differentiating malignant from benign thyroid neoplasms. The analysis of intensity and distribution of galectin-3 expression could improve the specificity of the method.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
134-1342428-2430 - Karcinogeneza u štitnjači i gušavost u Hrvatskoj (Kusić, Zvonko, MZOS ) ( CroRIS)
Ustanove:
KBC "Sestre Milosrdnice",
Klinički bolnički centar Rijeka
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- MEDLINE
- Science Citation Index Expanded